Exact Sciences Terminates SEC Registration

TL;DR

EXAS just ditched SEC reporting requirements. Less public info incoming.

AI Summary

Exact Sciences Corp. filed a Form 15-12G on April 2, 2026, to terminate the registration of its securities under Section 12(g) of the Securities Exchange Act. This action indicates the company no longer meets the criteria for mandatory SEC reporting.

Why It Matters

This filing suggests Exact Sciences Corp. may no longer be required to file regular reports with the SEC, potentially reducing public disclosure requirements.

Risk Assessment

Risk Level: low — A 15-12G filing is a procedural step to terminate registration and does not inherently signal financial distress or operational issues.

Key Numbers

• 12(g) — Section 12(g) (The section of the Securities Exchange Act under which registration is being terminated.)

Key Players & Entities

• EXACT SCIENCES CORP (company) — Filer of the 15-12G form
• 0001124140 (company) — CIK number for EXACT SCIENCES CORP
• 0001193125-26-138856 (filing_id) — SEC Accession Number for the filing
• 2026-04-02 (date) — Filing Date and Effectiveness Date

FAQ

Key Financial Figures

• $0.01 — ipal executive offices) Common Stock, $0.01 par value per share 0.3750% Convertib

Filing Documents

• d39912d1512g.htm (15-12G) — 12KB
• 0001193125-26-138856.txt ( ) — 13KB

From the Filing

15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-35092 Exact Sciences Corporation (Exact name of registrant as specified in its charter) Exact Sciences Corporation 5505 Endeavor Lane Madison, WI 53719 Tel: (608) 284-5700 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) Common Stock, $0.01 par value per share 0.3750% Convertible Senior Notes due 2027 0.3750% Convertible Senior Notes due 2028 Preferred Stock* Debt Securities* Warrants* Rights* (Title of each class of securities covered by this Form) None (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains) Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports: Rule 12g-4(a)(1) Rule 12g-4(a)(2) Rule 12h-3(b)(1)(i) Rule 12h-3(b)(1)(ii) Rule 15d-6 Rule 15d-22(b) Approximate number of holders of record as of the certification or notice date: Common Stock, $0.01 par value per share: 1 0.3750% Convertible Senior Notes due 2027: Less than 300 0.3750% Convertible Senior Notes due 2028: Less than 300 Preferred Stock, Debt Securities, Warrants, Rights: 0 * Unissued securities registered under automatic shelf registration statement on Form S-3 (File No. 333-272196) Pursuant to the requirements of the Securities Exchange Act of 1934, Exact Sciences Corporation has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person. Date: April 2, 2026 Exact Sciences Corporation By: /s/ James R. Wenner Name: James R. Wenner Title: Vice President and Treasurer

View Full Filing

View this 15-12G filing on SEC EDGAR